SCHEMBL18370625

SCHEMBL18370625

c1ccc(-c2ccc(-c3cccc(-c4cccc(-c5nc(-c6cccc(-c7cccc(-c8ccc(-c9ccccc9)cc8)c7)c6)c6c(n5)oc5ccccc56)c4)c3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.42
▸ PLA2G4A P47712 4/20 0.42
▸ PLA2G10 O15496 1/20 0.39
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ TBK1 Q9UHD2 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ WHR1 P49842 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ TERT O14746 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370628 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370636 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370633 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370614 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370624 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370613 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370620 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18370606 1.00 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18017886 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A
SCHEMBL18018018 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PLA2G2A 4615/4885PLA2G4A 4381/4885PLA2G10 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback